{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:56:05Z","timestamp":1789674965263,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Opioids are widely prescribed for the treatment of moderate to severe pain. Gastro-intestinal side effects are common with opioid use, of which opioid-induced constipation (OIC) is the most prevalent. OIC can be difficult to manage, and may lead to increased healthcare utilization, including emergency department (ED) visits. However, data on the prevalence of OIC in the ED are limited. We conducted a retrospective, single-center study of 2017 adult long-acting opioid users presenting to the ED between 2016 and 2022. OIC was diagnosed in 129 patients (6.4%; 95%\u00a0CI 5.4\u20137.6%). Treatment included dose escalation of existing laxatives (37%), initiation of additional laxatives (25%), administration of enemas (47%) and use of peripherally acting \u00b5-opioid receptor antagonists (16%). A modest dose- and treatment time-response effect was observed, with higher opioid doses and longer treatment durations slightly increasing the risk of OIC at ED presentation. Cancer patients had significantly higher odds of having OIC at their ED visits compared to non-cancer patients (OR 8.81; 95%\u00a0CI 5.89\u201313.17;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), while sex was not associated with OIC (OR 0.84; 95%\u00a0CI 0.56\u20131.28). Oxycodone use was linked to higher odds of OIC (OR 1.95; 95%\u00a0CI 1.30\u20132.91), whereas tramadol use was associated with a significantly lower risk of OIC. 23 patients revisited the ED within 30 days due to OIC, and there were three deaths related to OIC. These findings highlight the clinically relevant burden of OIC in the ED, particularly among cancer patients and oxycodone users. Clinical awareness of OIC is needed, especially in patients with increased risk.\n                  <\/jats:p>","DOI":"10.1007\/s11739-026-04466-z","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:32:12Z","timestamp":1784611932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence of opioid-induced constipation in the emergency department: a retrospective study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8467-2135","authenticated-orcid":false,"given":"Kay Robin Jonathan","family":"Kistemaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith Francisca Anthonia","family":"Rakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Schober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trynke","family":"Hoekstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"de Graeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoutar","family":"Azijli-Abdellaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique Anna Henrica","family":"Steegers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"van Zuylen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"2","key":"4466_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/2040622315627801","volume":"7","author":"AD Nelson","year":"2016","unstructured":"Nelson AD, Camilleri M (2016) Opioid-induced constipation: advances and clinical guidance. Ther Adv Chronic Dis 7(2):121\u2013134","journal-title":"Ther Adv Chronic Dis"},{"issue":"1","key":"4466_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/2050640618818305","volume":"7","author":"AD Farmer","year":"2019","unstructured":"Farmer AD, Drewes AM, Chiarioni G, De Giorgio R, O\u2019Brien T, Morlion B et al (2019) Pathophysiology and management of opioid-induced constipation: European expert consensus statement. United Eur Gastroenterol J 7(1):7\u201320","journal-title":"United Eur Gastroenterol J"},{"issue":"1","key":"4466_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/j.pain.0000000000002024","volume":"162","author":"A Davies","year":"2021","unstructured":"Davies A, Leach C, Butler C, Gregory A, Henshaw S, Minton O et al (2021) Opioid-induced constipation in patients with cancer: a \u201creal-world,\u201d multicentre, observational study of diagnostic criteria and clinical features. Pain 162(1):309\u2013318","journal-title":"Pain"},{"issue":"3","key":"4466_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5055\/jom.2009.0014","volume":"5","author":"T Bell","year":"2009","unstructured":"Bell T, Annunziata K, Leslie JB (2009) Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey. J Opioid Manag 5(3):137\u2013144","journal-title":"J Opioid Manag"},{"key":"4466_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.sjpain.2015.12.007","volume":"11","author":"HN Christensen","year":"2016","unstructured":"Christensen HN, Olsson U, From J, Breivik H (2016) Opioid-induced constipation, use of laxatives, and health-related quality of life. Scand J Pain 11:104\u2013110","journal-title":"Scand J Pain"},{"issue":"5","key":"4466_CR6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/0269216312450358","volume":"27","author":"L Dhingra","year":"2013","unstructured":"Dhingra L, Shuk E, Grossman B, Strada A, Wald E, Portenoy A et al (2013) A qualitative study to explore psychological distress and illness burden associated with opioid-induced constipation in cancer patients with advanced disease. Palliat Med 27(5):447\u2013456","journal-title":"Palliat Med"},{"issue":"1","key":"4466_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1053\/j.gastro.2018.07.016","volume":"156","author":"SD Crockett","year":"2019","unstructured":"Crockett SD, Greer KB, Heidelbaugh JJ, Falck-Ytter Y, Hanson BJ, Sultan S et al (2019) American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation. Gastroenterology 156(1):218\u2013226","journal-title":"Gastroenterology"},{"key":"4466_CR8","unstructured":"Palliaweb. Guideline Constipation in the palliative phase. Available from: https:\/\/palliaweb.nl\/richtlijnen-palliatieve-zorg\/richtlijn\/obstipatie\/preventie\/opioidgeinduceerde-obsitapatie. Accessed 12 Jun 2025"},{"issue":"Suppl 4","key":"4466_CR9","doi-asserted-by":"publisher","first-page":"iv111","DOI":"10.1093\/annonc\/mdy148","volume":"29","author":"PJ Larkin","year":"2018","unstructured":"Larkin PJ, Cherny NI, La Carpia D, Guglielmo M, Ostgathe C, Scotte F et al (2018) Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. Ann Oncol 29(Suppl 4):iv111\u2013iv125","journal-title":"Ann Oncol"},{"issue":"12","key":"4466_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2025.112857","volume":"56","author":"TU Bresgen","year":"2025","unstructured":"Bresgen TU, Salinaro F, Barcella B, Perlini S, Mascherona I, Di Pietro S (2025) Acute pain management of rib fractures: a narrative review. Injury 56(12):112857","journal-title":"Injury"},{"issue":"12","key":"4466_CR11","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1111\/anae.16695","volume":"80","author":"S Di Pietro","year":"2025","unstructured":"Di Pietro S, Maffeis R, Jannelli E, Mascia B, Resta F, De Silvestri A et al (2025) Comparing the pericapsular nerve group block and fascia iliaca block for acute pain management in patients with hip fracture: a randomised clinical trial. Anaesthesia 80(12):1484\u20131492","journal-title":"Anaesthesia"},{"issue":"6","key":"4466_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/JTN.0000000000000250","volume":"23","author":"D Sullivan","year":"2016","unstructured":"Sullivan D, Lyons M, Montgomery R, Quinlan-Colwell A (2016) Exploring opioid-sparing multimodal analgesia options in trauma: a nursing perspective. J Trauma Nurs 23(6):361\u2013375","journal-title":"J Trauma Nurs"},{"key":"4466_CR13","doi-asserted-by":"crossref","unstructured":"Khemani D, Camilleri M, Roldan A, Nelson AD, Park SY, Acosta A, et al. (2017) Opioid analgesic use among patients presenting with acute abdominal pain and factors associated with surgical diagnoses. Neurogastroenterol Motil; 29(5)","DOI":"10.1111\/nmo.13000"},{"issue":"3","key":"4466_CR14","first-page":"160","volume":"9","author":"AW Fernandes","year":"2016","unstructured":"Fernandes AW, Kern DM, Datto C, Chen YW, McLeskey C, Tunceli O (2016) Increased burden of healthcare utilization and cost associated with opioid-related constipation among patients with noncancer pain. Am Health Drug Benefits 9(3):160\u2013170","journal-title":"Am Health Drug Benefits"},{"issue":"1","key":"4466_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jpainsymman.2006.07.011","volume":"33","author":"P Villars","year":"2007","unstructured":"Villars P, Dodd M, West C, Koetters T, Paul SM, Schumacher K et al (2007) Differences in the prevalence and severity of side effects based on type of analgesic prescription in patients with chronic cancer pain. J Pain Symptom Manage 33(1):67\u201377","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"4466_CR16","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1007\/s11864-022-00976-y","volume":"23","author":"T Dzierzanowski","year":"2022","unstructured":"Dzierzanowski T, Mercadante S (2022) Constipation in cancer patients - an update of clinical evidence. Curr Treat Options Oncol 23(7):936\u2013950","journal-title":"Curr Treat Options Oncol"},{"key":"4466_CR17","unstructured":"Palliaweb. Guideline Pain in cancer patients in the palliative phase. Available from: https:\/\/palliaweb.nl\/richtlijnen-palliatieve-zorg\/richtlijn\/pijn-bij-patienten-met-kanker. Accessed 12 Jun 2025"},{"issue":"10","key":"4466_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-024-08898-1","volume":"32","author":"A Davies","year":"2024","unstructured":"Davies A, Fagan N, Gonzalez-Barboteo J, Chelazzi C, Economos G, Elsner F et al (2024) Inadequate management of opioid-induced constipation in European cancer pain patients: results of a real-world, multicentre, observational study (\u201cE-StOIC\u201d). Support Care Cancer 32(10):701","journal-title":"Support Care Cancer"},{"issue":"4","key":"4466_CR19","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s00520-019-04996-7","volume":"28","author":"EJ Roeland","year":"2020","unstructured":"Roeland EJ, Sera CJ, Ma JD (2020) More opioids, more constipation? Evaluation of longitudinal total oral opioid consumption and self-reported constipation in patients with cancer. Support Care Cancer 28(4):1793\u20131797","journal-title":"Support Care Cancer"},{"issue":"7","key":"4466_CR20","volume":"17","author":"S Fumita","year":"2025","unstructured":"Fumita S, Imai H, Harada T, Akashi Y, Koretaka Y, Morioka Y et al (2025) The relationship between opioid dose and opioid-induced constipation in Japanese patients with cancer pain: a post hoc analysis of a prospective observational cohort study. Cureus 17(7):e87697","journal-title":"Cureus"},{"issue":"4","key":"4466_CR21","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1365-2982.2009.01458.x","volume":"22","author":"AK Tuteja","year":"2010","unstructured":"Tuteja AK, Biskupiak J, Stoddard GJ, Lipman AG (2010) Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain. Neurogastroenterol Motil 22(4):424\u2013430","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"4466_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12916-025-04118-7","volume":"23","author":"BB Yimer","year":"2025","unstructured":"Yimer BB, Soomro M, McBeth J, Medina CRR, Lunt M, Dixon WG et al (2025) Comparative risk of severe constipation in patients treated with opioids for non-cancer pain: a retrospective cohort study in Northwest England. BMC Med 23(1):288","journal-title":"BMC Med"},{"issue":"4","key":"4466_CR23","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.mayocp.2020.10.004","volume":"96","author":"SP Narayanan","year":"2021","unstructured":"Narayanan SP, Anderson B, Bharucha AE (2021) Sex- and gender-related differences in common functional gastroenterologic disorders. Mayo Clin Proc 96(4):1071\u20131089","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"4466_CR24","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1177\/2050640616659967","volume":"5","author":"P Ducrott\u00e9","year":"2017","unstructured":"Ducrott\u00e9 P, Milce J, Soufflet C, Fabry C (2017) Prevalence and clinical features of opioid-induced constipation in the general population: a French study of 15,000 individuals. United Eur Gastroenterol J 5(4):588\u2013600","journal-title":"United Eur Gastroenterol J"},{"issue":"1","key":"4466_CR25","first-page":"25","volume":"1","author":"A Rumman","year":"2016","unstructured":"Rumman A, Gallinger ZR, Liu LWC (2016) Opioid induced constipation in cancer patients: pathophysiology, diagnosis and treatment. Expert Rev Qual Life Cancer Care 1(1):25\u201335","journal-title":"Expert Rev Qual Life Cancer Care"},{"issue":"2","key":"4466_CR26","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s40122-021-00271-y","volume":"10","author":"G Varrassi","year":"2021","unstructured":"Varrassi G, Banerji V, Gianni W, Marinangeli F, Pinto C (2021) Impact and consequences of opioid-induced constipation: a survey of patients. Pain Ther 10(2):1139\u20131153","journal-title":"Pain Ther"},{"issue":"1","key":"4466_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/SPC.0b013e3282f53146","volume":"2","author":"KE Clemens","year":"2008","unstructured":"Clemens KE, Klaschik E (2008) Management of constipation in palliative care patients. Curr Opin Support Palliat Care 2(1):22\u201327","journal-title":"Curr Opin Support Palliat Care"},{"key":"4466_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00414","volume":"7","author":"RM McQuade","year":"2016","unstructured":"McQuade RM, Stojanovska V, Abalo R, Bornstein JC, Nurgali K (2016) Chemotherapy-induced constipation and diarrhea: pathophysiology, current and emerging treatments. Front Pharmacol 7:414","journal-title":"Front Pharmacol"},{"key":"4466_CR29","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.031","author":"F Mearin","year":"2016","unstructured":"Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M et al (2016) Bowel disorders. Gastroenterology. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.031","journal-title":"Gastroenterology"},{"issue":"1","key":"4466_CR30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1185\/03007995.2010.535270","volume":"27","author":"AM Rentz","year":"2011","unstructured":"Rentz AM, van Hanswijck de Jonge P, Leyendecker P, Hopp M (2011) Observational, nonintervention, multicenter study for validation of the Bowel Function Index for constipation in European countries. Curr Med Res Opin 27(1):35\u201344","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"4466_CR31","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3111\/13696990903430481","volume":"12","author":"AM Rentz","year":"2009","unstructured":"Rentz AM, Yu R, Muller-Lissner S, Leyendecker P (2009) Validation of the Bowel Function Index to detect clinically meaningful changes in opioid-induced constipation. J Med Econ 12(4):371\u2013383","journal-title":"J Med Econ"},{"key":"4466_CR32","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.2147\/JPR.S318564","volume":"14","author":"F Coluzzi","year":"2021","unstructured":"Coluzzi F, Alvaro D, Caraceni AT, Gianni W, Marinangeli F, Massazza G et al (2021) Common clinical practice for opioid-induced constipation: a physician survey. J Pain Res 14:2255\u20132264","journal-title":"J Pain Res"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04466-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11739-026-04466-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-026-04466-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:32:23Z","timestamp":1784611943000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11739-026-04466-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":32,"alternative-id":["4466"],"URL":"https:\/\/doi.org\/10.1007\/s11739-026-04466-z","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The medical ethical committee of Amsterdam UMC declared that the study did not fall within the scope of theMedical Research Involving Human Subject Act (WMO). Although the study was classifi ed as non-WMO research,applicable Dutch privacy legislation (AVG\/GDPR) required that patients be informed and given the opportunity toobject to use of their data prior to accessing their electronic health records.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}